← Back to Search

Other

Internet Survey for Psoriasis

N/A
Waitlist Available
Led By William H Huang, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will assess patients' adherence to oral psoriasis treatment and also collect pilot data on an intervention to improve adherence.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to prescribed oral Methotrexate treatment
Patterns of Misuse
Psoriasis severity outcomes
Secondary outcome measures
Relationship to Adherence
Relationship to Satisfaction

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Internet SurveyExperimental Treatment1 Intervention
Subject will receive an electronic survey weekly to complete
Group II: No SurveyActive Control1 Intervention
No intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Internet Survey
2016
Completed Early Phase 1
~70

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,244 Previous Clinical Trials
1,004,720 Total Patients Enrolled
12 Trials studying Psoriasis
974 Patients Enrolled for Psoriasis
PfizerIndustry Sponsor
4,573 Previous Clinical Trials
10,923,322 Total Patients Enrolled
67 Trials studying Psoriasis
172,548 Patients Enrolled for Psoriasis
William H Huang, MDPrincipal InvestigatorWake Forest

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical experiment currently enrolling participants?

"According to clinicaltrials.gov, the recruitment period for this research has been concluded and no new participants are being sought out. The trial first appeared on April 1st 2016 before its eventual closure on November 30th 2022. However, 171 other studies still remain active with a need for volunteers."

Answered by AI
Recent research and studies
Archives of DermatologyJournal
Low Blood Concentration of Hydroxychloroquine in Patients with Refractory Cutaneous Lupus Erythematosus
Cosnes, Anne. 2012. “Low Blood Concentration of Hydroxychloroquine in Patients with Refractory Cutaneous Lupus Erythematosus”. Archives of Dermatology. American Medical Association (AMA). doi:10.1001/archdermatol.2011.2558.
Clinical PharmacokineticsJournal
The Electronic Medication Event Monitor
Urquhart, John. 1997. “The Electronic Medication Event Monitor”. Clinical Pharmacokinetics. Springer Science and Business Media LLC. doi:10.2165/00003088-199732050-00001.
Health and Quality of Life OutcomesJournal
[]
Atkinson, Mark J, Anusha Sinha, Steven L Hass, Shoshana S Colman, Ritesh N Kumar, Meryl Brod, and Clayton R Rowland. 2004. “[]”. Health and Quality of Life Outcomes. Springer Science and Business Media LLC. doi:10.1186/1477-7525-2-12.
DrugsJournal
Issues in Patient Compliance
Murphy, Judy, and Gregor Coster. 1997. “Issues in Patient Compliance”. Drugs. Springer Science and Business Media LLC. doi:10.2165/00003495-199754060-00002.
~3 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top